Akebia TherapeuticsAKBA
那斯達克 · USD
1.37
-0.03
(-2.14%)
盤中 03/13 01:44 (UTC+8)
03/13 01:44 (UTC+8)
Akebia TherapeuticsAKBA
1.37
-0.03
(-2.14%)
財務數據
損益表
- 0.42
- 0.56
- 0.33
- 0.44
- 0.37
- 0.46
- 0.57
- 0.62
- 0.59
- 0.58
- -25.26
- 33.65
- -41.98
- 33.86
- -14.25
- 24.23
- 23.31
- 8.96
- -5.93
- -1.95
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | |
營業收入淨額 | 57,622 | 58,766 | 62,472 | 57,336 | 46,497 | 37,428 | 43,648 | 32,607 | 56,196 | 42,046 |
營業成本 | 12,535 | 9,383 | 9,919 | 7,625 | 20,365 | 14,161 | 17,046 | 11,605 | 18,665 | 18,011 |
營業毛利 | 45,087 | 49,383 | 52,553 | 49,711 | 26,132 | 23,267 | 26,602 | 21,002 | 37,531 | 24,035 |
營業費用 | 53,640 | 44,934 | 38,464 | 36,197 | - | - | - | - | 36,157 | 37,071 |
研發費用 | 26,648 | 14,944 | 11,013 | 9,754 | 11,786 | 8,487 | 7,648 | 9,731 | 9,865 | 13,331 |
推銷及管理費用 | 26,992 | 29,990 | 27,451 | 26,443 | 28,653 | 27,285 | 27,678 | 26,149 | 26,292 | 23,571 |
非經常性項目費用 | - | - | - | - | - | - | - | 58 | - | 169 |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -8,553 | 4,449 | 14,089 | 13,514 | -14,307 | -12,505 | -8,724 | -14,936 | 1,374 | -13,036 |
其他收入及費用 | 2,145 | 1,454 | -7,008 | 368 | -1,620 | -873 | 2,291 | -551 | 658 | -43 |
利息費用 | 4,827 | 4,748 | 6,834 | 7,770 | 6,877 | 6,661 | 2,149 | 2,498 | 1,418 | 1,410 |
稅前純益 | -11,235 | 1,155 | 247 | 6,112 | -22,804 | -20,039 | -8,582 | -17,985 | 614 | -14,489 |
所得稅 | 1,009 | 615 | - | - | - | - | - | - | - | - |
稅後純益 | -12,244 | 540 | 247 | 6,112 | -22,804 | -20,039 | -8,582 | -17,985 | 614 | -14,489 |
基本每股稅後盈餘(元) | -0.05 | 0.00 | 0.00 | 0.03 | -0.10 | -0.10 | -0.04 | -0.09 | 0.00 | -0.08 |
稀釋每股稅後盈餘(元) | -0.05 | 0.01 | -0.01 | 0.03 | -0.11 | -0.09 | -0.04 | -0.09 | 0.00 | -0.08 |
基本平均股數(千股) | 265783.00 | 264786.00 | 262565.00 | 235497.00 | 218699.00 | 210348.00 | 209705.00 | 204955.00 | 189903.00 | 188306.00 |
稀釋平均股數(千股) | 241553.00 | 274372.00 | 271104.00 | 241602.00 | 218699.00 | 210348.00 | 209705.00 | 204955.00 | 190496.00 | 188306.00 |
還原基本每股稅後盈餘(元) | -0.05 | 0.00 | 0.00 | 0.03 | -0.10 | -0.10 | -0.04 | -0.09 | 0.00 | -0.08 |
還原稀釋每股稅後盈餘(元) | -0.05 | 0.01 | -0.01 | 0.03 | -0.11 | -0.09 | -0.04 | -0.09 | 0.00 | -0.08 |
還原基本平均股數(千股) | 265,783 | 264,786 | 262,565 | 235,497 | 218,699 | 210,348 | 209,705 | 204,955 | 189,903 | 188,306 |
還原稀釋平均股數(千股) | 241,553 | 274,372 | 271,104 | 241,602 | 218,699 | 210,348 | 209,705 | 204,955 | 190,496 | 188,306 |
EBITDA(千元) | -6,087 | 6,221 | 7,397 | 14,196 | -2,384 | -4,004 | 2,977 | -6,112 | 13,427 | -3,672 |